Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 846 for “"Immune checkpoint"”.

  1. Characterising peripheral responses to immune checkpoint inhibitors

    <p>The introduction of immune checkpoint blockade (ICB) therapy for metastatic melanoma (MM) has dramatically improved survival in this patient group. However, only some patients experience durable clinical response, and many will develop immune-related adverse events (irAEs). The identification of …

    oxford Repository record for Characterising peripheral responses to immune checkpoint inhibitors (opens in a new tab)

  2. Manipulating immune checkpoint signalling pathways with antibodies

    <p>Immune checkpoint receptors are critical regulators of immune tolerance. Antibodies blocking these pathways can enhance immune responses and in recent years have revolutionised the treatment of cancer. The converse approach of developing agonistic antibodies against checkpoint receptors to …

    oxford Repository record for Manipulating immune checkpoint signalling pathways with antibodies (opens in a new tab)

  3. New approaches to treating cancer using immune-checkpoint blockade

    While immune-checkpoint blockade has truly revolutionised cancer treatment in many aspects, the benefits remain limited to certain tumour types. Furthermore, within those tumours that are likely to improve upon treatment, only a fraction of patients actually respond, which highlights the need for …

    oxford Repository record for New approaches to treating cancer using immune-checkpoint blockade (opens in a new tab)

  4. Macrophage polarization and colorectal cancer immune checkpoint protein expression.

    … requires the expression of cell surface immune checkpoint proteins (e.g. PDL1) to exert its effect. Most (>85%) of colorectal cancers do not express these proteins and this contributes in part to the poor prognosis and survival in patients with advanced disease. The patients in which …

    louisville Repository record for Macrophage polarization and colorectal cancer immune checkpoint protein expression. (opens in a new tab)

  5. Reversing AML microenvironment-mediated immunosuppression using immune checkpoint inhibitors

    … and AML cells, as well as the effect of using immune checkpoint inhibitors in reversing the suppressed T lymphocyte activity. Methods: The in vitro 3D biomimetic matrix model was developed using patient-derived bone marrow mesenchymal stromal cells (BM-MSC), AML cells, and peripheral blood …

    ku Repository record for Reversing AML microenvironment-mediated immunosuppression using immune checkpoint inhibitors (opens in a new tab)

  6. Regulation of the immune checkpoint PD-L1 by microRNAs

    … have critical roles in the regulation of immune responses and inflammation. The expression of PD-L1 protein is found on some normal and cancer cells and contributes to suppression of T cell activity by acting as a brake on the immune response. Previously, it has been shown that …

    whiterose Download PDF for Regulation of the immune checkpoint PD-L1 by microRNAs (opens in a new tab)

  7. Enzyme-mediated methylthioadenosine depletion as a novel immune checkpoint therapy

    … poor patient survival, and resistance to immune checkpoint therapies. Frequent MTAP loss in cancer leads to the accumulation of its substrate 5’-deoxy-5’-methylthioadenosine (MTA), which exerts potent immunosuppressive effects in T cells. We hypothesize that accumulated MTA in the tumor …

    texas Repository record for Enzyme-mediated methylthioadenosine depletion as a novel immune checkpoint therapy (opens in a new tab)

  8. SILENCING XRN1 ENHANCED THE EFFECT OF IMMUNE CHECKPOINT BLOCKADE THERAPY

    Despite the remarkable achievement of immune checkpoint blockade (ICB) therapy, the response rate is relatively low and only a subset of patients can benefit from the treatment. We hypothesize that targeting RNA decay machinery may lead to accumulation of aberrant-RNA, triggering interferon (IFN) …

    nus Repository record for SILENCING XRN1 ENHANCED THE EFFECT OF IMMUNE CHECKPOINT BLOCKADE THERAPY (opens in a new tab) Download file for SILENCING XRN1 ENHANCED THE EFFECT OF IMMUNE CHECKPOINT BLOCKADE THERAPY (opens in a new tab)

  9. Pulsed photothermal therapy as a precondition for immune checkpoint blockade

    … can trigger certain physiological responses like immune stimulation and cytokine secretion. This immune response can be reinforced in combination with cancer immunotherapies such as immune checkpoint blockade. Although research has demonstrated that pulsed lasers generate more localized heating …

    ubc Repository record for Pulsed photothermal therapy as a precondition for immune checkpoint blockade (opens in a new tab) Download PDF for Pulsed photothermal therapy as a precondition for immune checkpoint blockade (opens in a new tab)

  10. Persistent Cancer Cells Alter Interferon Signaling After Immune Checkpoint Blockade

    Immune checkpoint blockade (ICB) therapies represent a groundbreaking paradigm in cancer treatment, reshaping clinical approaches. Despite their efficacy, relapse remains a common challenge with poorly understood acquired resistance mechanisms. In this study, leveraging multiple mouse models of ICB …

    penn Repository record for Persistent Cancer Cells Alter Interferon Signaling After Immune Checkpoint Blockade (opens in a new tab)

  11. RNA Knockdown of the Immune Checkpoint VISTA Promotes Tumor Regression

    Blockade of negative immune regulators for example CTLA-4, and PD-1/PD-L1 has proven to be a clinically effective strategy to enhance tumor specific immune responses. Recently discovered novel immunoglobulin superfamily ligand V-domain Ig suppressor of T-cell Activation (VISTA) is a new target for …

    uthsc Repository record for RNA Knockdown of the Immune Checkpoint VISTA Promotes Tumor Regression (opens in a new tab)

  12. Outcomes of Immune Checkpoint Inhibitor-Mediated Colitis: Multicenter Cohort Study

    Immune checkpoint inhibitor (ICI)-mediated colitis (IMC) is a common and serious toxicity. Multiple reports have described the clinical presentation and course of IMC based on limited data. This was a collaborative effort from several cancer institutes to investigate features and outcomes of IMC. …

    umkc Repository record for Outcomes of Immune Checkpoint Inhibitor-Mediated Colitis: Multicenter Cohort Study (opens in a new tab)

  13. Immune checkpoint inhibitor-induced inflammatory arthritis: a single center review

    INTRODUCTION: Immune checkpoint inhibitors are a new form of immunotherapy that has transformed the treatment landscape for an ever-increasing number of malignancies. While these medications utilize and enhance the immune system to treat malignancies, they can also have significant side effects, …

    bu Repository record for Immune checkpoint inhibitor-induced inflammatory arthritis: a single center review (opens in a new tab)

  14. Development of an MSC-based immune checkpoint inhibiting cell therapy

    … has focused on targeted therapy, particularly immune checkpoint therapies, since programmed cell death protein 1 (PD1) monoclonal therapies demonstrated notable efficacy with reduced toxicity. Despite its progress to date, several challenges persist, including a non-inflammatory tumour …

    essex Download PDF for Development of an MSC-based immune checkpoint inhibiting cell therapy (opens in a new tab)

  15. MULTI-OMIC APPROACHES TO UNDERSTAND TUMOR EVOLUTION DURING IMMUNE CHECKPOINT INHIBITION

    Immune checkpoint inhibitors (ICIs), have transformed cancer therapeutics across cancers, however a sizable fraction of patients eventually develop therapy resistance. Therefore, it is essential to identify which patients would attain the most benefit from ICIs. This has triggered many studies …

    jhu Repository record for MULTI-OMIC APPROACHES TO UNDERSTAND TUMOR EVOLUTION DURING IMMUNE CHECKPOINT INHIBITION (opens in a new tab) Embargoed until 2028-08-01

  16. COMBINATION EPIGENETIC THERAPY CAN SENSITIZE OVARIAN CANCER TO IMMUNE CHECKPOINT THERAPY

    While immune checkpoint blockade is approved for other solid tumors, such as non-small cell lung cancer, melanoma, kidney cancer, and bladder cancer, it has not yet been successfully used in ovarian cancer. Ovarian cancer is the leading cause of death from gynecological malignancies in the United …

    jhu Repository record for COMBINATION EPIGENETIC THERAPY CAN SENSITIZE OVARIAN CANCER TO IMMUNE CHECKPOINT THERAPY (opens in a new tab)

  17. THE ROLE OF IMMUNE CHECKPOINT PD-L1 IN HOMEOSTASIS AND INFLAMMATION

    Immune related adverse events associated with the use of checkpoint inhibitor therapies to treat multiple types of cancer highlight the importance of immune checkpoint molecules in the maintenance of tissue homeostasis and protection against autoimmune diseases. We investigated the role of the …

    jhu Repository record for THE ROLE OF IMMUNE CHECKPOINT PD-L1 IN HOMEOSTASIS AND INFLAMMATION (opens in a new tab)

  18. Bhlhe40: Required For Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy

    … Hodi et al., 2010). Immunotherapy, specifically immune checkpoint therapy (ICT) provides antagonist effect on specific immune checkpoints to control effector T cell functions(Pardoll, 2012). This therapy allows for the modulation of anti-tumor responses through the use of monoclonal antibodies, …

    uthsc Repository record for Bhlhe40: Required For Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy (opens in a new tab)

Page 1 of 43